|
Rossari Biotech Ltd.
|
Ratio Analysis
|
|
|
You can view the
Ratio Analysis
for the last 5 years.
|
Market Cap. (Rs.)
|
2806.42 Cr.
|
P/BV
|
2.19
|
Book Value (Rs.)
|
231.78
|
|
52 Week High/Low (Rs.)
|
766/375
|
FV/ML
|
2/1
|
P/E(X)
|
18.81
|
|
Bookclosure
|
20/06/2025
|
EPS (Rs.)
|
26.94
|
Div Yield (%)
|
0.10
|
|
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
| FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| | | | | | |
| PER SHARE RATIOS | | | | | |
| | | | | | |
| Basic EPS (Rs.) | 26.95 | 24.66 | 23.67 | 19.46 | 17.81 |
| Diluted EPS (Rs.) | 26.93 | 24.63 | 23.62 | 19.38 | 17.70 |
| Cash EPS (Rs.) | 40.88 | 36.57 | 34.56 | 30.68 | 26.19 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 240.74 | 214.12 | 189.65 | 165.93 | 146.25 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 240.74 | 214.12 | 189.65 | 165.93 | 146.25 |
| Revenue From Operations / Share (Rs.) | 432.67 | 375.74 | 331.35 | 300.22 | 269.36 |
| PBDIT / Share (Rs.) | 55.66 | 48.60 | 46.56 | 41.43 | 35.50 |
| PBIT / Share (Rs.) | 41.38 | 36.49 | 35.63 | 30.02 | 26.77 |
| PBT / Share (Rs.) | 36.22 | 33.27 | 32.12 | 25.97 | 24.47 |
| Net Profit / Share (Rs.) | 26.60 | 24.46 | 23.62 | 19.27 | 17.46 |
| NP After MI And SOA / Share (Rs.) | 26.94 | 24.63 | 23.66 | 19.45 | 17.74 |
| | | | | | |
| PROFITABILITY RATIOS | | | | | |
| | | | | | |
| PBDIT Margin (%) | 12.86 | 12.93 | 14.05 | 13.79 | 13.17 |
| PBIT Margin (%) | 9.56 | 9.71 | 10.75 | 9.99 | 9.93 |
| PBT Margin (%) | 8.37 | 8.85 | 9.69 | 8.65 | 9.08 |
| Net Profit Margin (%) | 6.14 | 6.50 | 7.12 | 6.41 | 6.48 |
| NP After MI And SOA Margin (%) | 6.22 | 6.55 | 7.13 | 6.47 | 6.58 |
| Return on Networth / Equity (%) | 11.19 | 11.50 | 12.47 | 11.71 | 12.13 |
| Return on Capital Employeed (%) | 15.28 | 14.85 | 17.15 | 16.22 | 15.31 |
| Return On Assets (%) | 6.51 | 7.19 | 8.31 | 7.84 | 7.77 |
| Long Term Debt / Equity (X) | 0.07 | 0.08 | 0.03 | 0.03 | 0.00 |
| Total Debt / Equity (X) | 0.30 | 0.15 | 0.10 | 0.08 | 0.01 |
| Asset Turnover Ratio (%) | 1.15 | 1.20 | 1.25 | 1.26 | 1.63 |
| | | | | | |
| LIQUIDITY RATIOS | | | | | |
| | | | | | |
| Current Ratio (X) | 1.58 | 1.94 | 1.99 | 2.08 | 2.07 |
| Quick Ratio (X) | 1.06 | 1.28 | 1.32 | 1.54 | 1.42 |
| Inventory Turnover Ratio (X) | 6.31 | 6.53 | 5.22 | 5.70 | 6.80 |
| Dividend Payout Ratio (NP) (%) | 0.00 | 2.02 | 2.11 | 2.56 | 2.81 |
| Dividend Payout Ratio (CP) (%) | 0.00 | 1.35 | 1.44 | 1.61 | 1.88 |
| Earning Retention Ratio (%) | 0.00 | 97.98 | 97.89 | 97.44 | 97.19 |
| Cash Earning Retention Ratio (%) | 0.00 | 98.65 | 98.56 | 98.39 | 98.12 |
| | | | | | |
| COVERAGE RATIOS | | | | | |
| | | | | | |
| Interest Coverage Ratio (%) | 10.80 | 15.11 | 13.28 | 10.24 | 15.44 |
| Interest Coverage Ratio (Post Tax) (%) | 6.16 | 8.60 | 7.74 | 5.76 | 8.60 |
| | | | | | |
| VALUATION RATIOS | | | | | |
| | | | | | |
| Enterprise Value (Cr.) | 2410.99 | 3475.13 | 3801.34 | 3233.01 | 4985.62 |
| EV / Net Operating Revenue (X) | 1.01 | 1.67 | 2.08 | 1.95 | 3.36 |
| EV / EBITDA (X) | 7.82 | 12.91 | 14.78 | 14.15 | 25.51 |
| MarketCap / Net Operating Revenue (X) | 0.87 | 1.61 | 2.04 | 1.98 | 3.39 |
| Retention Ratios (%) | 0.00 | 97.97 | 97.88 | 97.43 | 97.18 |
| Price / BV (X) | 1.57 | 2.82 | 3.56 | 3.59 | 6.25 |
| Price / Net Operating Revenue (X) | 0.87 | 1.61 | 2.04 | 1.98 | 3.39 |
| EarningsYield | 0.07 | 0.04 | 0.03 | 0.03 | 0.01 |
